Menopause

2.1(top 20%)

impact factor

4.7K(top 5%)

papers

104.5K(top 5%)

citations

120(top 5%)

h-index

2.2(top 20%)

impact factor

5.7K

all documents

109.7K

doc citations

172(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The 2017 hormone therapy position statement of The North American Menopause Society	Menopause	2017	836
2	Executive summary of the Stages of Reproductive Aging Workshop + 10	Menopause	2012	824
3	Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis	Menopause	2006	597
4	The 2012 Hormone Therapy Position Statement of The North American Menopause Society	Menopause	2012	587
5	Management of symptomatic vulvovaginal atrophy	Menopause	2013	506
6	Genitourinary syndrome of menopause	Menopause	2014	484
7	Increased cardiovascular mortality after early bilateral oophorectomy	Menopause	2009	384
8	Management of osteoporosis in postmenopausal women	Menopause	2010	369
9	Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS)	Menopause	2006	362
10	Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society: Retracted	Menopause	2004	346
11	Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition *	Menopause	2003	312
12	Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy	Menopause	2014	296
13	Effect of Soy Protein Supplementation on Serum Lipoproteins, Blood Pressure, and Menopausal Symptoms in Perimenopausal Women	Menopause	1999	292
14	Vasomotor Symptom Relief by Soy Isoflavone Extract Tablets in Postmenopausal Women	Menopause	2000	276
15	Estrogen and progestogen use in postmenopausal women	Menopause	2010	266
16	Early menopause predicts future coronary heart disease and stroke	Menopause	2012	263
17	Effect of early menopause on bone mineral density and fractures	Menopause	2007	261
18	Longitudinal changes in sexual functioning as women transition through menopause	Menopause	2009	261
19	The North American Menopause Society Recommendations for Clinical Care of Midlife Women	Menopause	2014	258
20	Is there an association between menopause status and sexual functioning?	Menopause	2000	257
21	Nonhormonal management of menopause-associated vasomotor symptoms	Menopause	2015	257
22	Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition	Menopause	2004	247
23	Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women	Menopause	2008	247
24	Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women	Menopause	2003	246
25	Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition *	Menopause	2003	239
26	Associations of depression with the transition to menopause	Menopause	2010	237
27	The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society	Menopause	2020	235
28	Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women	Menopause	2009	233
29	Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women	Menopause	2006	230
30	Effects of intranasal 17β-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women	Menopause	2006	229
31	Depressed mood during the menopausal transition and early postmenopause	Menopause	2008	226
32	Short-term Effects of Phytoestrogen-rich Diet on Postmenopausal Women	Menopause	1997	214
33	Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition	Menopause	2005	211
34	Estrogen and progestogen use in postmenopausal women	Menopause	2008	211
35	Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women	Menopause	2010	211
36	Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy	Menopause	2013	210
37	The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)	Menopause	2019	204
38	Clinical Effects of a Standardized Soy Extract in Postmenopausal Women	Menopause	2000	203
39	Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN)	Menopause	2005	200
40	Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue	Menopause	2015	200
41	The impact of hormones on menopausal sexuality: a literature review	Menopause	2004	196
42	Estrogen therapy selectively enhances prefrontal cognitive processes	Menopause	2006	195
43	Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies	Menopause	2009	192
44	The role of anxiety and hormonal changes in menopausal hot flashes	Menopause	2005	187
45	Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials	Menopause	2004	186
46	Risk of long-term hot flashes after natural menopause	Menopause	2014	183
47	Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause	Menopause	2016	181
48	Management of osteoporosis in postmenopausal women	Menopause	2006	180
49	Cycle and hormone changes during perimenopause	Menopause	2008	180
50	17β-Estradiol Vaginal Tablet Versus Conjugated Equine Estrogen Vaginal Cream to Relieve Menopausal Atrophic Vaginitis	Menopause	2000	178

Scientometrics

Overviews

Citing Bodies

Menopause

Top Articles